(lp0
S"Tetraphase Pharmaceuticals Inc Is Climbing Again Today -- Here's Why Motley Fool - Mar 10, 2017 Shares of Tetraphase Pharmaceuticals Inc , a clinical-stage biotech developing antibiotics, continued its impressive climb with another gain of about 15.8%, as of 11:46 a.m.Tetraphase Pharmaceuticals, Inc. : A Detailed Look at its Institutional ... - Post AnalystTetraphase Pharmaceuticals Inc  Latest Earnings Release EPS Down By $-0.01 - Times Money"
p1
aS'Analyst Activity  Stifel Nicolaus Raises Its Price Target On Tetraphase ... Market Exclusive - Mar 9, 2017 Tetraphase Pharmaceuticals, Inc.  is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections.The Cigna Investments Inc. New Purchases Shares of 28876 Tetraphase ... - Petro Global News 24'
p2
aS"Tetraphase Pharmaceuticals, Ionis Pharmaceuticals, Facebook Stocks Moving Today Schaeffers Research  - Mar 10, 2017 The S&amp;P is set to snap a six-week winning streak, with traders turning their attention to next week's Fed decision after a blowout jobs report."
p3
aS'Tetraphase Pharmaceuticals Inc  Raised to Outperform at BMO Capital ... Chaffey Breeze - 19 hours ago Tetraphase Pharmaceuticals Inc logo BMO Capital Markets upgraded shares of Tetraphase Pharmaceuticals Inc  from a market perform rating to an outperform rating in a research report released on Friday.The Tetraphase Pharmaceuticals Inc  Upgraded to Outperform at BMO ... - Petro Global News 24Tetraphase Pharmaceuticals Inc.  Soars 11.8% on March 13 - Equities.com'
p4
aS'Tetraphase Pharmaceuticals Inc.  Breaks into New 52-Week High on March ... Equities.com - Mar 14, 2017 Shares of Tetraphase Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $7.98. Shares closed at $7.59 after opening at $7.95 for a move of -2.32%.'
p5
aS"Today's Research Reports on Biotech Stocks to Watch: Inotek Pharmaceuticals ... Yahoo Finance - Mar 13, 2017 NEW YORK, NY / ACCESSWIRE / March 13, 2017 / For biotech pharmaceutical companies, the FDA approval process is beyond critical for the financial health of the company and its stakeholders. Getting fast tracked by the FDA is a significant boost. Most of&nbsp;..."
p6
aS'Tetraphase Pharmaceuticals Inc  Sees Large Volume Increase on Analyst ... BNB Daily  - Mar 12, 2017 Tetraphase Pharmaceuticals logo Tetraphase Pharmaceuticals Inc  saw unusually-high trading volume on Friday after BMO Capital Markets upgraded the stock from a market perform rating to an outperform rating.'
p7
aS"Tetraphase Pharmaceuticals Doses First Patient in IGNITE3 Phase 3 Clinical ... GlobeNewswire  - Jan 17, 2017 WATERTOWN, Mass., Jan. 17, 2017  -- Tetraphase Pharmaceuticals, Inc.  today announced dosing of the first patient in IGNITE3, the Company's phase 3 clinical trial evaluating the efficacy and safety of once-daily&nbsp;..."
p8
aS'Market Focus: Checking in on Shares of Tetraphase Pharmaceuticals Inc  Baxter Review - 15 hours ago Tetraphase Pharmaceuticals Inc  has a current 14-day RSI reading of 75.29, the 7-day is 75.61, and the 3-day is 69.3.'
p9
aS'Tetraphase Pharmaceuticals Reports Second Quarter 2016 Financial Results and ... GlobeNewswire  - Aug 4, 2016 04, 2016  -- Tetraphase Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant  infections, today reported financial results for ...'
p10
a.